Agree. Also, no brain bleeding and no deaths in 9 plus years of positive drug trial results with Blarcamesine. Also should be taken in consideration. Imo
La Flaca...you say at this 'juncture' they are delving into trial design, data sources. Huh? What do you think they having been doing since December of 2024 (8 months of review). I would think at this point they are making sure safety measures are in place??
Market Data 
Markets 
